Attached files

file filename
EX-31.1 - EXHIBIT 31.1 - VERTEX PHARMACEUTICALS INC / MAvrtx10k_2015-exhibit311.htm
EX-23.1 - EXHIBIT 23.1 - VERTEX PHARMACEUTICALS INC / MAvrtx10k_2015-exhibit231.htm
EX-31.2 - EXHIBIT 31.2 - VERTEX PHARMACEUTICALS INC / MAvrtx10k_2015-exhibit312.htm
EX-10.35 - EXHIBIT 10.35 - VERTEX PHARMACEUTICALS INC / MAvrtx10-k2015xexhibit1035.htm
EX-10.41 - EXHIBIT 10.41 - VERTEX PHARMACEUTICALS INC / MAvrtx10k_2015-exhibit1041.htm
EX-10.27 - EXHIBIT 10.27 - VERTEX PHARMACEUTICALS INC / MAvrtx10k_2015-exhibit1027.htm
EX-10.25 - EXHIBIT 10.25 - VERTEX PHARMACEUTICALS INC / MAvrtx10k_2015-exhibit1025.htm
EX-10.10 - EXHIBIT 10.10 - VERTEX PHARMACEUTICALS INC / MAvrtx10k_2015-exhibit1010.htm
EX-10.34 - EXHIBIT 10.34 - VERTEX PHARMACEUTICALS INC / MAvrtx10-k_2015xexhibit1034.htm
10-K - 10-K - VERTEX PHARMACEUTICALS INC / MAa201510k-main.htm
EX-21.1 - EXHIBIT 21.1 - VERTEX PHARMACEUTICALS INC / MAvrtx10k_2015-exhibit211.htm
EX-10.6 - EXHIBIT 10.6 - VERTEX PHARMACEUTICALS INC / MAvrtx10k_2015-exhibit106.htm
EX-32.1 - EXHIBIT 32.1 - VERTEX PHARMACEUTICALS INC / MAvrtx10k_2015-exhibit321.htm


Exhibit 10.42

Vertex Pharmaceuticals Non-Employee Board Compensation
 
 
 
 
Annual Retainer
$85,000
 
 
 
 
 
Committee Chair Compensation
 
 
 
Audit & Finance Committee Chair
$30,000 annual retainer
 
Management Development & Compensation Committee Chair
$25,000 annual retainer
 
Corporate Governance & Nominating Committee Chair
$20,000 annual retainer
 
Science & Technology Committee Chair
$20,000 annual retainer
 
 
 
Committee Membership Fee (Non Chairs)
 
 
Audit & Finance Committee Member
$15,000 annual retainer
 
Management Development & Compensation Committee Member
$10,000 annual retainer
 
Corporate Governance & Nominating Committee Member
$10,000 annual retainer
 
Science & Technology Committee Member
$10,000 annual retainer
 
 
 
 
Lead Independent Director Compensation
$40,000 annual retainer
 
 
 
 
Equity Grants
 
 
 
Upon first election to the Board, a $550,000 value-based award, based on a 50/50 mix of restricted stock and options
    Options vesting quarterly over four years
    Restricted stock vesting annually over four years
 
On June 1 on each year of service, a $550,000 value-based award, based on a 50/50 mix of restricted stock and options
    Options are fully vested upon grant
    Restricted shares cliff vest on the 1 year anniversary of the grant date
 
 
 
 
Each of our non-employee directors is eligible to defer the cash and restricted stock portion of his/her compensation set forth above and elect to receive deferred stock units that convert to common stock in specified circumstances.